CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 481 enrolled
Drug / intervention
lidocaine +1 moredrug
Likely dose
lidocaine 2mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01330134
NCT01330134Phase 4Completed

Comparison of Two Lidocaine Administration Techniques

University of Chicago·interventional·Posted Apr 6, 2011·Updated Jul 26, 2018

In Brief

A Phase 4 clinical trial evaluating lidocaine for Pain. Completed, enrolled 481 participants across 1 site.

Detailed Summary

The objective of our study is to determine if technique of lidocaine administration can decrease pain perception. Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are given only subcutaneous injection by standard approach.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 6, 2011
Enrollment StartFeb 1, 2011
Primary CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 15.2 years ago

Interventions

lidocainedrug

2ml 1% lidocaine placed onto surface of the skin immediately prior to 1% lidocaine subcutaneous injection

lidocainedrug

1% lidocaine subcutaneous injection alone